Dr Reddys Laboratories Ltd.
| BSE: 500124 | Sector: Health care |
| NSE: DRREDDY | ISIN Code: INE089A01023 |
| BSE 16:00 | 11 May | 5293.60 |
-35.50 (-0.67%) |
OPEN
5329.10 |
HIGH
5349.85 |
LOW
5272.00 |
| NSE 15:58 | 11 May | 5295.95 |
-31.60 (-0.59%) |
OPEN
5325.00 |
HIGH
5349.95 |
LOW
5271.30 |
| OPEN | 5329.10 |
| PREVIOUS CLOSE | 5329.10 |
| VOLUME | 61728 |
| 52-Week high | 5514.65 |
| 52-Week low | 3613.45 |
| P/E | 37.02 |
| Mkt Cap.(Rs cr) | 88,033 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Dr Reddys Laboratories Ltd. (DRREDDY) - Announcements
-
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Credit Rating
08/05/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Updates on Acquisition
30/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
29/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
29/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
23/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligation
19/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Shareholding for the Period Ended March 31 2021
16/04/2021 | bse
-
Dr Reddys Laboratories Ltd Compliance Certificate For The Period Ended March 31 2021
15/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
13/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
09/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Statement Of Investor Complaints For The Quarter Ended March 2021
08/04/2021 | bse
-
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
07/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Updates on Acquisition
01/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
01/04/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Updates on Acquisition
31/03/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Announcement under Regulation 30 (LODR)-Acquisition
31/03/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011
30/03/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Board to consider FY21 results & Dividend on May 14 2021
29/03/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Closure of Trading Window
29/03/2021 | bse |
Downlaod PDF -
Dr Reddys Laboratories Ltd Board Meeting Intimation for Board Meeting Intimation For Audited Financial Results
29/03/2021 | bse |
Downlaod PDF
Quick Links for Dr Reddys Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
